With Nebula Genomics, researchers can sponsor the sequencing of patients or healthy individuals.
Study participants receive their raw genetic data and a report at no cost.
The study sponsor receives access to genetic data and can use it for research purposes.
Lung Cancer Study
EMD Serono, the biopharma business of Merck KGaA, Darmstadt, Germany in the U.S. and Canada,
collaborates with Nebula Genomics to sponsor whole genome sequencing for a cohort of lung cancer patients.
Read more on our blog.
Nebula handles the hard parts of getting a study off the ground
Using our large community and a network of advocacy partners, we can source patients that
match a wide range of eligibility criteria.
CONSENT & IRB APPROVAL
We put the required approvals in place and collect consent from study participants.
SAMPLE COLLECTION SEQUENCING
We can retrieve and sequence a variety of biospecimen.